Zobrazeno 1 - 10
of 135
pro vyhledávání: '"John A. Auchampach"'
Autor:
Xinrui Wang, Tina C. Wan, Katherine R. Kulik, Amelia Lauth, Brian C. Smith, John W. Lough, John A. Auchampach
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 5 (2023)
Externí odkaz:
https://doaj.org/article/0c1b7ee7c7c248fc8962ed361b293697
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Autor:
Dilip K. Tosh, Antonella Ciancetta, Philip Mannes, Eugene Warnick, Aaron Janowsky, Amy J. Eshleman, Elizabeth Gizewski, Tarsis F. Brust, Laura M. Bohn, John A. Auchampach, Zhan-Guo Gao, Kenneth A. Jacobson
Publikováno v:
ACS Omega, Vol 3, Iss 10, Pp 12658-12678 (2018)
Externí odkaz:
https://doaj.org/article/1e1f1e1e4506436da0e5c5de6c1ad211
Publikováno v:
Disease Models & Mechanisms, Vol 13, Iss 12 (2020)
Regeneration of muscle in the damaged myocardium is a major objective of cardiovascular research, for which purpose many investigators utilize mice containing transgenes encoding Cre recombinase to recombine loxP-flanked target genes. An unfortunate
Externí odkaz:
https://doaj.org/article/54b9efe1e5d24442843d267a611c1569
Autor:
Courtney L. Fisher, Lucas B. Fallot, Tina C. Wan, Robert F. Keyes, R. Rama Suresh, Amy C. Rothwell, Zhan-Guo Gao, John D. McCorvy, Brian C. Smith, Kenneth A. Jacobson, John A. Auchampach
Publikováno v:
ACS Pharmacology & Translational Science. 5:625-641
Autor:
Kenneth Jacobson, Courtney Fisher, Veronica Salmaso, Tina C. Wan, Ryan G. Campbell, Eric Chen, Zhan-Guo Gao, John A. Auchampach, Dilip K. Tosh
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development.
Autor:
Courtney Fisher, Veronica Salmaso, Tina C. Wan, Balaram Pradhan, Kenneth Jacobson, John A. Auchampach
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development.
Publikováno v:
Purinergic Signalling.
Autor:
Tina C. Wan, Alexandra L. Purdy, John Lough, Xinrui Wang, Katherine R. Kulik, Michaela Patterson, Amelia Lauth, John A. Auchampach
Publikováno v:
J Mol Cell Cardiol
Injury from myocardial infarction (MI) and consequent post-MI remodeling is accompanied by massive loss of cardiomyocytes (CM), a cell type critical for contractile function that is for all practical purposes non-regenerable due to its profound state
Autor:
Lucas B, Fallot, R Rama, Suresh, Courtney L, Fisher, Veronica, Salmaso, Robert D, O'Connor, Noy, Kaufman, Zhan-Guo, Gao, John A, Auchampach, Kenneth A, Jacobson
Publikováno v:
Journal of medicinal chemistry. 65(22)
We previously reported 1
Autor:
Xinrui Wang, Tina C. Wan, Katherine R. Kulik, Amelia Lauth, Brian C. Smith, John W. Lough, John A. Auchampach
Publikováno v:
Disease Models & Mechanisms. 16
Pharmacologic strategies that target factors with both pro-apoptotic and anti-proliferative functions in cardiomyocytes (CMs) may be useful for the treatment of ischemic heart disease. One such multifunctional candidate for drug targeting is the acet